BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Taheri M, Shoorei H, Tondro Anamag F, Ghafouri-Fard S, Dinger ME. LncRNAs and miRNAs participate in determination of sensitivity of cancer cells to cisplatin. Exp Mol Pathol 2021;:104602. [PMID: 33422487 DOI: 10.1016/j.yexmp.2021.104602] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Huni KC, Cheung J, Sullivan M, Robison WT, Howard KM, Kingsley K. Chemotherapeutic Drug Resistance Associated with Differential miRNA Expression of miR-375 and miR-27 among Oral Cancer Cell Lines. Int J Mol Sci 2023;24. [PMID: 36674758 DOI: 10.3390/ijms24021244] [Reference Citation Analysis]
2 Ebrahimi N, Faghihkhorasani F, Fakhr SS, Moghaddam PR, Yazdani E, Kheradmand Z, Rezaei-tazangi F, Adelian S, Mobarak H, Hamblin MR, Aref AR. Tumor-derived exosomal non-coding RNAs as diagnostic biomarkers in cancer. Cell Mol Life Sci 2022;79:572. [DOI: 10.1007/s00018-022-04552-3] [Reference Citation Analysis]
3 Fu L, Zhang D, Yi N, Cao Y, Wei Y, Wang W, Li L. Circular RNA circPBX3 promotes cisplatin resistance of ovarian cancer cells via interacting with IGF2BP2 to stabilize ATP7A mRNA expression. Hum Cell 2022. [PMID: 35907138 DOI: 10.1007/s13577-022-00748-8] [Reference Citation Analysis]
4 Elfert AY, Salem A, Abdelhamid AM, Salama A, Sourour DA, Shaker O, Keshk M. Implication of miR-122, miR-483, and miR-335 Expression Levels as Potential Signatures in HCV-Related Hepatocellular Carcinoma (HCC) in Egyptian Patients. Front Mol Biosci 2022;9:864839. [DOI: 10.3389/fmolb.2022.864839] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Sheng S, Su W, Mao D, Li C, Hu X, Deng W, Yao Y, Ji Y. MicroRNA-21 induces cisplatin resistance in head and neck squamous cell carcinoma. PLoS One 2022;17:e0267017. [PMID: 35421166 DOI: 10.1371/journal.pone.0267017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Dai S, Liu T, Liu YY, He Y, Liu T, Xu Z, Wang ZW, Luo F. Long Non-Coding RNAs in Lung Cancer: The Role in Tumor Microenvironment. Front Cell Dev Biol 2021;9:795874. [PMID: 35047506 DOI: 10.3389/fcell.2021.795874] [Reference Citation Analysis]
7 Pehlivanoglu B, Unlu SM. Biomarkers in Gastrointestinal System Carcinomas. Biomarkers in Carcinoma of Unknown Primary 2022. [DOI: 10.1007/978-3-030-84432-5_7] [Reference Citation Analysis]
8 Zhang R, Zhao H, Yuan H, Wu J, Liu H, Sun S, Zhang Z, Wang J. CircARVCF Contributes to Cisplatin Resistance in Gastric Cancer by Altering miR-1205 and FGFR1. Front Genet 2021;12:767590. [PMID: 34899853 DOI: 10.3389/fgene.2021.767590] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Zhu Z, Ma L. Sevoflurane induces inflammation in primary hippocampal neurons by regulating Hoxa5/Gm5106/miR-27b-3p positive feedback loop. Bioengineered 2021. [PMID: 34783294 DOI: 10.1080/21655979.2021.2005927] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Abadi AJ, Mirzaei S, Mahabady MK, Hashemi F, Zabolian A, Hashemi F, Raee P, Aghamiri S, Ashrafizadeh M, Aref AR, Hamblin MR, Hushmandi K, Zarrabi A, Sethi G. Curcumin and its derivatives in cancer therapy: Potentiating antitumor activity of cisplatin and reducing side effects. Phytother Res 2021. [PMID: 34697839 DOI: 10.1002/ptr.7305] [Cited by in Crossref: 31] [Cited by in F6Publishing: 36] [Article Influence: 15.5] [Reference Citation Analysis]
11 Hu Y, Ma Y, Luo G, Liao W, Zhang S, Li G. Effect of MiR-375 Regulates YAP1 on the Invasion, Apoptosis, and Epithelial-Mesenchymal Transition of Cervical Cancer HeLa Cells. Evid Based Complement Alternat Med 2021;2021:3088723. [PMID: 34512774 DOI: 10.1155/2021/3088723] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Tang W, Zhu S, Liang X, Liu C, Song L. The Crosstalk Between Long Non-Coding RNAs and Various Types of Death in Cancer Cells. Technol Cancer Res Treat 2021;20:15330338211033044. [PMID: 34278852 DOI: 10.1177/15330338211033044] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
13 Sun B, Hu N, Cong D, Chen K, Li J. MicroRNA-25-3p promotes cisplatin resistance in Non-small-cell lung carcinoma (NSCLC) through adjusting PTEN/PI3K/AKT route. Bioengineered 2021;12:3219-28. [PMID: 34266345 DOI: 10.1080/21655979.2021.1939577] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
14 Dong YJ, Feng W, Li Y. HOTTIP-miR-205-ZEB2 Axis Confers Cisplatin Resistance to Ovarian Cancer Cells. Front Cell Dev Biol 2021;9:707424. [PMID: 34322490 DOI: 10.3389/fcell.2021.707424] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]